Drug Topics

JULY 12, 2025

"I think it's really important, as we move to 2026 and beyond, we figure out ways to help pharmacies ease that burden and diversify their business." Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips. Subscribe Now!

Community Pharmacies 247

Community Pharmacies Independent Pharmacies Patient Care Specialty Pharmacies 247

Drug Topics

JUNE 6, 2025

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? 2026 Edition. To read these stories and more, download the PDF of the Drug Topics May/June issue here. Sign up today for our free Drug Topics newsletter. REFERENCES 1. Yellow Book. Updated April 23, 2025.

Vaccines 341

Vaccines Immunization Compounding Specialty Pharmacies 341

Drug Topics

JUNE 17, 2025

Positive results have been announced from a phase 2a clinical trial evaluating the safety, pharmacokinetics and efficacy of PP405 for the treatment of androgenetic alopecia in adult patients, Pelage Pharmaceuticals announced in a release. 1 The company said it plans to initiate phase 3 studies in 2026 to further evaluate the therapy.

Specialty Pharmacies 324

Specialty Pharmacies Compounding Independent Pharmacies Immunization 324

Drug Topics

JULY 10, 2025

The FDA has accepted for review a New Drug Application (NDA) for doravirine/islatravir for adult patients with HIV-1 infection that is virologically suppressed on antiretroviral therapy, Merck announced in a release. 1 The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. References 1. Subscribe Now!

FDA 247

FDA Vaccines Specialty Pharmacies Compounding 247

Drug Topics

JUNE 23, 2025

With rising drug costs, evolving health care regulations, and challenging reimbursement models, pharmacies must adopt strategic approaches to maintain financial health and continue providing patient care.

Patient Care 247

Patient Care Vaccines Specialty Pharmacies Compounding 247

Drug Topics

JUNE 10, 2025

Merck said in the release that it anticipates ordering of clesrovimab-cfor to begin in July, with shipments being delivered before the start of the 2025-2026 RSV season. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.

FDA 430

FDA Vaccines Adverse Reactions Specialty Pharmacies 430

Pharmacy Times

JUNE 10, 2025

All graduates should be ready for this, as our present Accreditation Council for Pharmacy Education Standards explicitly states: "Ensure that graduating students are ‘practice-ready’ and ‘team-ready,’ that is, prepared to directly contribute to patient care working in collaboration with other health care providers."

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65